- Home
- IRIX vs APM Comparison
IRIX vs APM Comparison
Compare IRIX & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRIX
- APM
- Stock Information
- Founded
- IRIX 1989
- APM 2010
- Country
- IRIX United States
- APM United Kingdom
- Employees
- IRIX N/A
- APM N/A
- Industry
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- IRIX Health Care
- APM Health Care
- Exchange
- IRIX Nasdaq
- APM Nasdaq
- Market Cap
- IRIX 20.2M
- APM 18.9M
- IPO Year
- IRIX 1996
- APM 2018
- Fundamental
- Price
- IRIX $1.04
- APM $1.39
- Analyst Decision
- IRIX
- APM
- Analyst Count
- IRIX 0
- APM 0
- Target Price
- IRIX N/A
- APM N/A
- AVG Volume (30 Days)
- IRIX 36.0K
- APM 113.6K
- Earning Date
- IRIX 11-11-2025
- APM 12-19-2025
- Dividend Yield
- IRIX N/A
- APM N/A
- EPS Growth
- IRIX N/A
- APM N/A
- EPS
- IRIX N/A
- APM N/A
- Revenue
- IRIX $49,744,000.00
- APM N/A
- Revenue This Year
- IRIX $9.61
- APM N/A
- Revenue Next Year
- IRIX N/A
- APM N/A
- P/E Ratio
- IRIX N/A
- APM N/A
- Revenue Growth
- IRIX 0.09
- APM N/A
- 52 Week Low
- IRIX $0.78
- APM $0.46
- 52 Week High
- IRIX $1.95
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- IRIX 42.91
- APM 35.35
- Support Level
- IRIX $1.00
- APM $1.43
- Resistance Level
- IRIX $1.10
- APM $1.43
- Average True Range (ATR)
- IRIX 0.04
- APM 0.08
- MACD
- IRIX 0.01
- APM -0.01
- Stochastic Oscillator
- IRIX 38.49
- APM 9.27
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.